{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T14:00:53Z","timestamp":1780668053264,"version":"3.54.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Health Serv Res"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>UK national guidance recommends systematic screening for latent tuberculosis infection (LTBI) in under-served populations, including people experiencing homelessness and people who use drugs. This is not routinely implemented in the UK, and the reasons for this policy-practice mismatch remain underexplored.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Semi-structured qualitative interviews were conducted with 19 healthcare professionals from across the UK. Participants were recruited using purposive sampling and snowballing, identifying individuals with excellent knowledge of their regions practice and policy of LTBI management. The interviews were conducted online, and were audio recorded, with transcripts thematically analysed using a two-stage inductive coding process to explore perceived barriers and enablers to LTBI screening.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Most participants had previous experience managing LTBI in under-served populations, but none were conducting systematic screening as per national guidance. We identified service provision challenges and low prioritisation of LTBI as the key explanatory themes driving this policy-practice mismatch. Lack of resource, and the complexity of clinical decision making were two key service level barriers. System and service inertia, and lack of cost effectiveness evidence led to LTBI being deprioritised. Service integration and promotion of WHO targets for TB elimination were highlighted as potential solutions.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Integrating LTBI testing and treatment with existing health services for under-served populations could improve feasibility and efficacy. Promotion of UK TB elimination goals and generation of regional evidence to support commissioning for LTBI care is vital. Without such a multi-pronged approach inertia is likely to persist and the zeitgeist will remain: \u201cit\u2019s too hard\u201d.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12913-022-08855-w","type":"journal-article","created":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T21:15:23Z","timestamp":1669929323000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["\u201cIt\u2019s too hard\u201d \u2013 the management of latent TB in under-served populations in the UK: a qualitative study"],"prefix":"10.1186","volume":"22","author":[{"given":"Adam Thorburn","family":"Gray","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian","family":"Surey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanif","family":"Esmail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alistair","family":"Story","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,12,1]]},"reference":[{"key":"8855_CR1","volume-title":"Consolidated guidelines on tuberculosis. Module 1: Prevention","author":"World Health Organisation","year":"2020","unstructured":"World Health Organisation. Consolidated guidelines on tuberculosis. Module 1: Prevention. Geneva: WHO; 2020."},{"issue":"6","key":"8855_CR2","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/S1473-3099(11)70069-X","volume":"11","author":"M Pareek","year":"2011","unstructured":"Pareek M, Watson JP, Ormerod LP, et al. Screening of immigrants in the UK for imported latent tuberculosis: a multicentre cohort study and cost-effectiveness analysis. Lancet Infect Dis. 2011;11(6):435\u201344.","journal-title":"Lancet Infect Dis."},{"key":"8855_CR3","unstructured":"National Institute for Health and Care Excellence. Tuberculosis [NICE Guideline 33). 2016. Available at: https:\/\/www.nice.org.uk\/guidance\/ng33. Accessed 23 Sep 2021."},{"key":"8855_CR4","unstructured":"Public Health England. Collaborative TB Strategy for England 2015\u20132020: End of programme report. Public Health England, London. 2021. Available at: https:\/\/www.gov.uk\/government\/publications\/collaborative-tuberculosis-strategy-for-england. Accessed 23 Sep 2021."},{"issue":"6","key":"8855_CR5","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/thoraxjnl-2016-209579","volume":"73","author":"RW Aldridge","year":"2018","unstructured":"Aldridge RW, Hayward AC, Hemming S, et al. High prevalence of latent tuberculosis and bloodborne virus infection in a homeless population. Thorax. 2018;73(6):557\u201364.","journal-title":"Thorax"},{"key":"8855_CR6","volume-title":"Tuberculosis in England, 2020 Report (presenting data to end of 2019)","author":"Public Health England","year":"2020","unstructured":"Public Health England. Tuberculosis in England, 2020 Report (presenting data to end of 2019). 2020."},{"key":"8855_CR7","doi-asserted-by":"crossref","unstructured":"Deiss RG, Rodwell TC, Garfein RS. Tuberculosis and drug use: review and update. Clin Infect Dis. 2009;48(1):72\u201382.","DOI":"10.1086\/594126"},{"issue":"3","key":"8855_CR8","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1001\/archinte.1979.03630400053020","volume":"139","author":"LB Reichman","year":"1979","unstructured":"Reichman LB, Felton CP, Edsall JR. Drug dependence, a possible new risk factor for tuberculosis disease. Arch Intern Med. 1979;139(3):337\u20139.","journal-title":"Arch Intern Med"},{"issue":"4","key":"8855_CR9","doi-asserted-by":"publisher","first-page":"082","DOI":"10.1093\/ofid\/ofw082","volume":"3","author":"A Yamin","year":"2016","unstructured":"Yamin A, Bornstein E, Hensel R, et al. Predictors of latent tuberculosis infection treatment after introduction of a new regimen: a retrospective cohort study at an inner city clinic. Open Forum Infect Dis. 2016;3(4):082.","journal-title":"Open Forum Infect Dis"},{"key":"8855_CR10","volume-title":"Tackling tuberculosis in under-served populations: a resource for TB control boards and their partners","author":"Public Health England","year":"2019","unstructured":"Public Health England. Tackling tuberculosis in under-served populations: a resource for TB control boards and their partners. 2019."},{"issue":"10117","key":"8855_CR11","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/S0140-6736(17)31869-X","volume":"391","author":"RW Aldridge","year":"2018","unstructured":"Aldridge RW, Story A, Hwang SW, et al. Morbidity and mortality in homeless individuals, prisoners, sex workers, and individuals with substance use disorders in high-income countries: a systematic review and meta-analysis. Lancet. 2018;391(10117):241\u201350.","journal-title":"Lancet"},{"key":"8855_CR12","volume-title":"TB action plan for England, 2021\u20132026","author":"UK Health Security Agency","year":"2021","unstructured":"UK Health Security Agency. TB action plan for England, 2021\u20132026. 2021."},{"issue":"7","key":"8855_CR13","doi-asserted-by":"publisher","first-page":"e0219252","DOI":"10.1371\/journal.pone.0219252","volume":"14","author":"I Spruijt","year":"2019","unstructured":"Spruijt I, Erkens C, Suurmond J, et al. Implementation of latent tuberculosis infection screening and treatment among newly arriving immigrants in the Netherlands: a mixed methods pilot evaluation. PLoS ONE. 2019;14(7):e0219252.","journal-title":"PLoS ONE"},{"issue":"2","key":"8855_CR14","doi-asserted-by":"publisher","first-page":"e158","DOI":"10.1002\/hsr2.158","volume":"3","author":"L Faust","year":"2020","unstructured":"Faust L, Ruhwald M, Schumacher S, et al. How are high burden countries implementing policies and tools for latent tuberculosis infection? A survey of current practices and barriers. Health Sci Rep. 2020;3(2):e158.","journal-title":"Health Sci Rep"},{"issue":"6","key":"8855_CR15","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1093\/intqhc\/mzm042","volume":"19","author":"A Tong","year":"2007","unstructured":"Tong A, Sainsbury P, Craig J. Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. Int J Qual Health Care. 2007;19(6):349\u201357.","journal-title":"Int J Qual Health Care"},{"issue":"2","key":"8855_CR16","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1191\/1478088706qp063oa","volume":"3","author":"V Braun","year":"2006","unstructured":"Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol. 2006;3(2):77\u20131101.","journal-title":"Qual Res Psychol"},{"issue":"5","key":"8855_CR17","doi-asserted-by":"publisher","first-page":"2100167","DOI":"10.1183\/13993003.00167-2021","volume":"58","author":"Y Hamada","year":"2021","unstructured":"Hamada Y, Cirillo DM, Matteelli A, et al. Tests for tuberculosis infection: landscape analysis. Eur Respir J. 2021;58(5):2100167.","journal-title":"Eur Respir J"},{"key":"8855_CR18","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1056\/NEJMcp2108501","volume":"385","author":"M Shah","year":"2021","unstructured":"Shah M, Dorman SE. Latent tuberculosis infection. N Engl J Med. 2021;385:2271\u201380.","journal-title":"N Engl J Med"},{"key":"8855_CR19","doi-asserted-by":"publisher","first-page":"113183","DOI":"10.1016\/j.socscimed.2020.113183","volume":"260","author":"M Harris","year":"2020","unstructured":"Harris M. Normalised pain and severe health care delay among people who inject drugs in London: Adapting cultural safety principles to promote care. Soc Sci Med. 2020;260:113183.","journal-title":"Soc Sci Med"},{"issue":"6","key":"8855_CR20","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1097\/NNR.0000000000000545","volume":"70","author":"A Nyamathi","year":"2021","unstructured":"Nyamathi A, Salem BE, Shin SS, et al. Effect of a nurse-led community health worker intervention on latent tuberculosis medication completion among homeless adults. Nurs Res. 2021;70(6):433\u201342.","journal-title":"Nurs Res"},{"issue":"2","key":"8855_CR21","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1097\/PHH.0000000000000822","volume":"25","author":"KM Schmit","year":"2019","unstructured":"Schmit KM, Lobato MN, Lang SG, et al. High completion rate for 12 weekly doses of isoniazid and rifapentine as treatment for latent mycobacterium tuberculosis infection in the federal bureau of prisons. J Public Health Manag Pract. 2019;25(2):e1-6.","journal-title":"J Public Health Manag Pract"},{"issue":"4","key":"8855_CR22","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1097\/ADM.0b013e31828d05ab","volume":"7","author":"B Honarvar","year":"2013","unstructured":"Honarvar B, Lankarani KB, Odoomi N, et al. Pulmonary and latent tuberculosis screening in opiate drug users: an essential and neglected approach for harm-reduction facilities. J Addict Med. 2013;7(4):230\u20135.","journal-title":"J Addict Med"},{"key":"8855_CR23","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.1056\/NEJMoa1104875","volume":"365","author":"TR Sterling","year":"2011","unstructured":"Sterling TR, Villarino ME, Borisov AS, et al. Three months of rifapentine and isoniazid for latent tuberculosis infection. N Engl J Med. 2011;365:2155\u201366.","journal-title":"N Engl J Med"},{"issue":"3","key":"8855_CR24","doi-asserted-by":"publisher","first-page":"e0213524","DOI":"10.1371\/journal.pone.0213524","volume":"14","author":"N Nwana","year":"2019","unstructured":"Nwana N, Marks SM, Lan E, et al. Treatment of latent Mycobacterium tuberculosis infection with 12 once weekly directly-observed doses of isoniazid and rifapentine among persons experiencing homelessness. PLoS ONE. 2019;14(3):e0213524.","journal-title":"PLoS ONE"},{"issue":"2","key":"8855_CR25","doi-asserted-by":"publisher","first-page":"2001718","DOI":"10.1183\/13993003.01718-2020","volume":"56","author":"CF McQuaid","year":"2020","unstructured":"McQuaid CF, McCreesh N, Read JM, et al. The potential impact of COVID-19-related disruption on tuberculosis burden. Eur Respir J. 2020;56(2):2001718.","journal-title":"Eur Respir J"},{"issue":"1","key":"8855_CR26","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1002\/hpm.2670","volume":"34","author":"DA Milinkovic","year":"2019","unstructured":"Milinkovic DA, Birch S, Scott F, et al. Low prioritization of latent tuberculosis infection \u2013 a systemic barrier to tuberculosis control: a qualitative study in Ontario Canada. Int J Health Plan Manage. 2019;34(1):384\u201395.","journal-title":"Int J Health Plan Manage"},{"key":"8855_CR27","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1186\/s12879-015-1091-9","volume":"15","author":"C Atchison","year":"2015","unstructured":"Atchison C, Zenner D, Barnett L, et al. Treating latent TB in primary care: a survey of enablers and barriers among UK general practitioners. BMC Infect Dis. 2015;15:331.","journal-title":"BMC Infect Dis"},{"key":"8855_CR28","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1186\/1472-6963-12-222","volume":"12","author":"R Canavan","year":"2012","unstructured":"Canavan R, Barry MM, Matanov A, et al. Service provision and barriers to care for homeless people with mental health problems across 14 European capital cities. BMC Health Serv Res. 2012;12:222.","journal-title":"BMC Health Serv Res"},{"issue":"1","key":"8855_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/hsc.12857","volume":"28","author":"P Omerov","year":"2020","unstructured":"Omerov P, Craftman AG, Mattsson E, et al. Homeless persons\u2019 experiences of health- and social care: a systematic integrative review. Health Soc Care Comm. 2020;28(1):1\u201311.","journal-title":"Health Soc Care Comm"},{"issue":"7","key":"8855_CR30","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1093\/cid\/cix505","volume":"65","author":"AL Sandul","year":"2017","unstructured":"Sandul AL, Nwana N, Hoilcombe JM, et al. High rate of treatment completion in program settings with 12-dose weekly isoniazid and rifapentine for latent mycobacterium tuberculosis infection. Clin Infect Dis. 2017;65(7):1085\u201393.","journal-title":"Clin Infect Dis"},{"issue":"3","key":"8855_CR31","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1183\/13993003.01464-2015","volume":"47","author":"ST Hoff","year":"2016","unstructured":"Hoff ST, Peter JG, Theron G, et al. Sensitivity of C-TB: a novel RD-1-specific skin test for the diagnosis of tuberculosis infection. Eur Respir J. 2016;47(3):919\u201328.","journal-title":"Eur Respir J"},{"issue":"126","key":"8855_CR32","doi-asserted-by":"publisher","first-page":"108318","DOI":"10.1016\/j.jsat.2021.108318","volume":"16","author":"DJ Rinehart","year":"2021","unstructured":"Rinehart DJ, Stowell M, Collings A, et al. Increasing access to family planning services among women receiving medications for opioid use disorder: a pilot randomized trial examining a peer-led navigation intervention. J Subst Abuse Treat. 2021;16(126):108318.","journal-title":"J Subst Abuse Treat"},{"issue":"10","key":"8855_CR33","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1016\/j.drugpo.2015.07.006","volume":"26","author":"J Keats","year":"2015","unstructured":"Keats J, Micallef M, Grebely J, et al. Assessment and delivery of treatment for hepatitis C virus infection in an opioid substitution treatment clinic with integrated peer-based support in Newcastle Australia. Int J Drug Policy. 2015;26(10):999\u20131006.","journal-title":"Int J Drug Policy"},{"key":"8855_CR34","doi-asserted-by":"publisher","first-page":"104687","DOI":"10.1016\/j.ijmedinf.2022.104687","volume":"159","author":"YJ Wong","year":"2022","unstructured":"Wong YJ, Ng KY, Lee SWH. Digital health use in latent tuberculosis infection care: a systematic review. Int J Med Inform. 2022;159:104687.","journal-title":"Int J Med Inform"},{"key":"8855_CR35","doi-asserted-by":"crossref","unstructured":"Story A, Garber E, Aldridge RW, et al. Management and control of tuberculosis control in socially complex groups: a research programme including three RCTs. Southampton (UK): NIHR Journals Library; 2020. PMID: 33119243","DOI":"10.3310\/pgfar08090"}],"container-title":["BMC Health Services Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-022-08855-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12913-022-08855-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-022-08855-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T21:15:30Z","timestamp":1669929330000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmchealthservres.biomedcentral.com\/articles\/10.1186\/s12913-022-08855-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,1]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["8855"],"URL":"https:\/\/doi.org\/10.1186\/s12913-022-08855-w","relation":{},"ISSN":["1472-6963"],"issn-type":[{"value":"1472-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,1]]},"assertion":[{"value":"26 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval was sought and received from University College London Research Ethics Committee [Ref: 21927.001]. Informed, written consent was sought from all participants.This study was carried out in accordance with the Helsinki declaration.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1464"}}